Fundraising Fox

Pulmonx Corp.

NASDAQ: LUNG

San Jose, US · Delaware corporation · 269 employees on LinkedIn · 4 known investors

Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery. The company operates in the medical device industry, serving pulmonologists and patients with severe emphysema through a minimally invasive lung treatment.

BiotechHealthtechMedical Devices

Founders & leadership

GE
GLENDON E. FRENCHFounder
LC
LAUREN CRISTINAExecutive
SRSri Radhakrishnan
Sri RadhakrishnanChief Technology Officer
MB
MICHAEL BAKERNamed on SEC filing
HP
HOWARD PALEFSKYNamed on SEC filing
DM
DANA MEADNamed on SEC filing
AC
ANNETTE CAMPBELL-WHITENamed on SEC filing

Board

DG
DANA G. MEAD, JRBoard director
SS
STEPHEN SALMONinBoard directorGeneral Partner at Latterell Venture Partners
MM
MICHAEL MATLYBoard director
SLSTAFFAN LINDSTRAND
STAFFAN LINDSTRANDin𝕏Board directorPartner at HealthCap
RF
RICH FERRARIBoard director

Investors · 4

Band of AngelsSilicon Valley
HealthCapStockholmvia Staffan Lindstrand · board
Kaiser Permanente VenturesSan Francisco · $2M – $5M
Latterell Venture PartnersSan Ramon · $50K – $10M

Funding

SEC filings, press & company announcements

$135.1M disclosed across 4 of 5 rounds · 2012–2026

▶$65.1MraisedApr 2019 · 18 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • STAFFAN LINDSTRANDDirector
  • LAUREN CRISTINAExecutive Officer
  • GLENDON E. FRENCHExecutive Officer, Director
  • RICH FERRARIDirector
  • MICHAEL MATLYDirector
  • STEPHEN SALMONDirector
  • DANA G. MEAD, JRDirector
  • CHARLES CHONDirector
  • OERN STUGEDirector
  • RODNEY PERKINS, M.D.Director
Offering amount
$65.1M
Amount sold
$65.1M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedApr 2017 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • GLENDON E. FRENCHExecutive Officer, Director
  • DANA G. MEAD, JRDirector
  • STEPHEN SALMONDirector
  • RODNEY PERKINS, M.D.Director
  • OERN STUGEDirector
  • MICHAEL MATLYDirector
  • LAUREN CRISTINAExecutive Officer
  • STAFFAN LINDSTRANDDirector
  • RICH FERRARIDirector
Offering amount
$50M
Amount sold
$50M
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedApr 2014 · 17 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • ANNETTE CAMPBELL-WHITEDirector
  • MARTIN SCHNEIDERExecutive Officer
  • HOWARD PALEFSKYDirector
  • STEVE SALMONDirector
  • MICHAEL BAKERExecutive Officer
  • LAUREN CRISTINAExecutive Officer
  • RODNEY PERKINS, M.D.Executive Officer, Director
  • STAFFAN LINDSTRANDDirector
  • RICH FERRARIDirector
  • DANA MEADDirector
Offering amount
$12M
Amount sold
$10M
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedFeb 2012 · 13 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • RICH FERRARIDirector
  • MICHAEL BAKERExecutive Officer, Director
  • HOWARD PALEFSKYDirector
  • STAFFAN LINDSTRANDDirector
  • RODNEY PERKINS, M.D.Director
  • DANA MEADDirector
  • ANNETTE CAMPBELL-WHITEDirector
  • STEVE SALMONDirector
Offering amount
$10M
Amount sold
$10M
First sale
Jan 2012
Incorporated
Corporation, California
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Medscape131 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Pulmonx Corp. for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Brokerages Set Pulmonx Corporation (NASDAQ:LUNG) PT at $5.58 - Defense Worlddefenseworld.net · Jul 2026Pulmonx to Release Q2 2026 Financial Results July 29 | LUNG Stock Newsstocktitan.net · Jul 2026Pulmonx Corporation Raises $66.0M | Signalbasetrysignalbase.com · May 2026Pulmonx, Inc. Raises $32 Million for Launch of Emphysema Products - BioSpacebiospace.com · Feb 2010Pulmonx News - Pulmonx Raises $32 Million for Launch of Emphysema Productspulmonx.com

Frequently asked questions

What does Pulmonx Corp. do?
Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery. The company operates in the medical device industry, serving pulmonologists and patients with severe emphysema through a minimally invasive lung treatment.
Who founded Pulmonx Corp.?
Pulmonx Corp. was founded by GLENDON E. FRENCH.
Who are Pulmonx Corp.'s investors?
Pulmonx Corp.'s investors include Band of Angels, HealthCap, Kaiser Permanente Ventures, Latterell Venture Partners.
How much funding has Pulmonx Corp. raised?
Pulmonx Corp. has disclosed $135.1M raised across 4 of its 5 known rounds.
Where is Pulmonx Corp. headquartered?
Pulmonx Corp. is headquartered in San Jose, US.